Increased cortisol level: A possible link between climacteric symptoms and cardiovascular risk factors

Menopause

Volumn 18, Issue 3, 2011, Pages 273-278

  Cagnacci, Angelo ^a   Cannoletta, Marianna ^a   Caretto, Simona ^a   Zanin, Renata ^a   Xholli, Anjeza ^a   Volpe, Annibale ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Cortisol; High density lipoprotein; Hot flash; Insulin resistance; Weight

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYDROCORTISONE URINE LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OUTPATIENT; POSTMENOPAUSE; RATING SCALE; SCORING SYSTEM; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; WAIST HIP RATIO;

BLOOD GLUCOSE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CLIMACTERIC; CROSS-SECTIONAL STUDIES; FEMALE; HOMEOSTASIS; HOT FLASHES; HUMANS; HYDROCORTISONE; INSULIN; INSULIN RESISTANCE; POSTMENOPAUSE; REGRESSION ANALYSIS; RISK FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 79952195050     PISSN: 10723714     EISSN: None     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181f31947     Document Type: Article

References (53)

1. Burger HG, Hale GE, Dennerstein L, Robertson DM. Cycle and hormone changes during perimenopause: the key role of ovarian function. Menopause 2008;15:603-612.
2. Prior JC. Ovarian aging and the perimenopause transition: the paradox of endogenous ovarian stimulation. Endocrine 2005;26:297-300. (Pubitemid 41271096)
3. Freeman EW, Sammel MD, Lin H. Temporal association of hot flashes and depression in the transition to menopause. Menopause 2009;16: 728-734.
4. Cagnacci A, Zanin R, Cannoletta M, Generali M, Caretto S, Volpe A. Menopause, estrogens, progestins or their combination on body weight and anthropometric measures. Fertil Steril 2007;88:1603-1608. (Pubitemid 350216839)
5. Janssen I, Powell LH, Kaziauskaite R, Dugan SA. Testosterone and visceral fat in midlife women: the Study of Women's Health Across the Nation (SWAN) fat patterning study. Obesity 2010;18:604-610.
6. Den Tonkelaar I, Seidell JC, van Noord PA. Obesity and fat distribution in relation to hot flashes. Maturitas 1996;23:301-305.
7. Freedman RR. Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med 2005;23:117-125. (Pubitemid 40604897)
8. Thurston RC, Sowers MR, Sutton-Tyrrell K, et al. Abdominal adiposity and hot flashes among midlife women. Menopause 2008;15:429-434. (Pubitemid 351656746)
9. Gerber LM, Sievert LL, Warren BA, Pickering TG, Schwartz JE. Hot flashes are associated with increased ambulatory systolic blood pressure. Menopause 2007;14:308-315. (Pubitemid 46673483)
10. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation heart study. Circulation 2008;118:1234-1240.
11. Bechlioulis A, Kalantaridou SN, Naka KK, et al. Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab 2010;95:1199-1206.
12. Gast GCM, Grobbee DE, Pop VJ, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008;51:1492-1498.
13. Tuomikoski P, Bert P, Groop PE, et al. Evidence for a role of hot flushes in vascular function in recently postmenopausal women. Obstet Gynecol 2009;113:902-908.
14. Tuomikoski P, Bert P, Groop PE, et al. Effect of hot flushes on vascular function. Obstet Gynecol 2009;114:777-785.
15. Gast GCM, Grobbee DE, Pop VJM, et al. Vasomotor symptoms are associated with a lower bone mineral density. Menopause 2009;16: 231-238.
16. Crandall CJ, Zheng Y, Crawford SL, et al. Presence of vasomotor symptoms is associated with lower bone mineral density. A longitudinal analysis. Menopause 2009;16:239-246.
17. Gupta P, Harte A, Sturdee DW, et al. Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implication for insulin resistance and cardiovascular risks. Climacteric 2008;11: 364-372.
18. Thurston RC, Christie IC, Matthews KA. Hot flashes and cardiac vagal control: a link to cardiovascular risk? Menopause 2010;17:456-461.
19. Meldrum DR, DeFazio JD, Erlik Y, et al. Pituitary hormones during the menopausal hot flash. Obstet Gynecol 1984;64:752-756. (Pubitemid 15219415)
20. Bromberger JT, Assman SF, Avis NE, et al. Persistent mood symptoms in a multiethnic community cohort of pre- and perimenopausal women. Am J Epidemiol 2003;158:347-356. (Pubitemid 41288802)
21. Cagnacci A, Volpe A, Arangino S, et al. Depression and anxiety in climacteric women: role of hormone replacement therapy. Menopause 1997;4:206-211. (Pubitemid 127729518)
22. Gold PW, Chrousos GP. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs. low CRH/NE states. Mol Psychiatry 2002;7:254-275. (Pubitemid 34280634)
23. McIsaac SA, Young AH. The role of hypothalamic pituitary-adrenal axis dysfunction in the etiology of depressive disorders. Drugs Today 2009; 45:127-133.
24. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyre PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10:19-28. (Pubitemid 36706318)
25. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435-1439. (Pubitemid 29494756)
26. Bose M, Olivan B, Laferrere B. Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease. Curr Opin Endocrinol Diabetes Obes 2009;16:340-346.
27. Müssig K, Remer T, Maser-Gluth C. Brief review: glucocorticoid excretion in obesity. J Steroid Biochem Mol Biol 2010;121:589-593.
28. Shaker JL, Lukert BP. Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am 2005;34:341-356. (Pubitemid 40602725)
29. Pasquali R, Vicennati V, Cacciari M, Pagotto U. The hypothalamicpituitary- adrenal axis activity in obesity and the metabolic syndrome. Ann N Y Acad Sci 2006;1083:111-128. (Pubitemid 44955469)
30. Wood NF, Carr MC, Tao EY, Taylor HJ, Mitchell ES. Increased urinary cortisol levels during the menopausal transition. Menopause 2006;13: 212-221.
31. Miller J, Crapo L. The biochemical diagnosis of hypercorticolism. Endocrinologist 1994;4:7-16.
32. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267-272. (Pubitemid 34002968)
33. Greene JG. Constructing a standard climacteric scale. Maturitas 1998;29: 25-31. (Pubitemid 28247565)
34. Spielberg CD, Gorsuch RL, Lusehene RE. Manual for the State-Trait Anxiety Inventory (Self-Evaluation Questionnaire). Palo Alto, CA: Consulting Psychologists Press, 1970.
35. Zung WWK. A self-rating depression scale. Arch Gen Psychol 1965;12:63-70.
36. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner DC. Homeostasis model assessment: insulin resistance and A-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
37. Baxter JD, Tyrrell JB. The adrenal cortex. In: Felig P, Baxter JD, Broadus AR, Frohman LA, eds. Endocrinology and Metabolism, 2nd ed. New York, NY: McGraw-Hill Book Company, 1987;511-650.
38. Mericq MV, Cutler GB JR. High fluid intake increases urine free cortisol excretion in normal subjects. J Clin Endocrinol Metab 1998;83:682-684. (Pubitemid 28496557)
39. SAS Publishing. StatView Reference, 3rd ed. Cary, NC: SAS Institute, 1999.
40. Kirschbaum C, Schommer N, Federenko I, et al. Short-term estradiol treatment enhances pituitary-adrenal axis and sympathetic responses to psychological stress in healthy young men. J Clin Endocrinol Metab 1996;81:3639-3643. (Pubitemid 26339930)
41. Cagnacci A, Soldani R, Yen SSC. Melatonin enhances cortisol levels in aged women: reversible by estrogens. J Pineal Res 1997;22:81-85. (Pubitemid 127731779)
42. Liu JH, Rasmussen DD, Rivier J, Vale W, Yen SSC. Pituitary responses to synthetic corticotropin-releasing hormone: absence of modulatory effects by estrogens and progestin. Am J Obstet Gynecol 1987;157: 1387-1391. (Pubitemid 18022862)
43. Slayden SM, Crabbe L, Bae S, Potter HD, Azziz R, Parker CR Jr. The effect of 17A-estradiol on adrenocortical sensitivity, responsiveness and steroidogenesis in postmenopausal women. J Clin Endocrinol Metab 1998;83:519-524. (Pubitemid 28496533)
44. Sapolsky RM, Krey LC, McEwen B. The neuroendocrinology of stress and ageing: the glucocorticoid cascade. Endocr Rev 1986;7:283-301.
45. Seeman TE, Robbins EJ. Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev 1994;15:233-260. (Pubitemid 24129184)
46. Bauer ME. Stress, glucocorticoids and ageing of the immune system. Stress 2005;8:69-83. (Pubitemid 40776474)
47. Lupien SJ, Fiocco A, Wan N, et al. Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 2005;30:225-242. (Pubitemid 39423357)
48. Lupien SJ, Nair NP, Brière S, et al. Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci 1999;10:117-139. (Pubitemid 29392579)
49. Bremner JD, Narayan M. The effects of stress on memory and the hippocampus throughout the life cycle: implications for childhood development and aging. Dev Psychopathol 1998;10:871-885. (Pubitemid 128435098)
50. Anagnostis P, Athyros VG, Tziomalas K, Karagiannis A, Mikhailidis DP. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009;94:2692-2701.
51. Pivonello R, Faggiano A, Lombardi G, Colao A. The metabolic syndrome and cardiovascular risk in Cushing's syndrome. Endocrinol Metab Clin North Am 2005;34:327-339. (Pubitemid 40602724)
52. Whitworth JA, Williamson PM, Mangos G, Kelly JJ. Cardiovascular consequences of cortisol excess. Vasc Health Risk Manage 2005;1:291-299.
53. Arnaldi G., Mancini T, Polenta B, Boscaro M. Cardiovascular risk in Cushing's syndrome. Pituitary 2004;7:253-256. (Pubitemid 43115861)